Skip to main content

Lusedra FDA Approval History

FDA Approved: Yes (Discontinued) (First approved December 12, 2008)
Brand name: Lusedra
Generic name: fospropofol disodium
Dosage form: Injection
Company: Eisai Inc.
Treatment for: Sedation

Marketing Status: Discontinued

Lusedra (fospropofol disodium) is an intravenous sedative-hypnotic agent for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.

Development timeline for Lusedra

DateArticle
Dec 15, 2008Approval FDA Approves Lusedra (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Jul 28, 2008Eisai Receives Action Letter on Fospropofol Disodium Injection for Sedation in Diagnostic or Therapeutic Procedures
Dec 17, 2007MGI Pharma Announces Aquavan NDA Accepted for Review by U.S. FDA
Sep 27, 2007MGI Pharma Announces Submission of Aquavan NDA

See also

Lusedra (fospropofol disodium) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer